Ulta Beauty, Inc.: Form 10-Q for the period ended Apr 29, 2023
Filed with the SEC on May 25, 2023 and accepted by EDGAR at May 25, 2023, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-04-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-29 to 2023-04-29 | $2.63bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-01-29 to 2023-04-29 | $1.58bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-01-29 to 2023-04-29 | $1.05bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-29 to 2023-04-29 | $612.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-29 to 2023-04-29 | $442.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-01-29 to 2023-04-29 | $102.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-29 to 2023-04-29 | $347.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-29 to 2023-04-29 | $6.88 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-29 to 2023-04-29 | $6.92 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-29 to 2023-04-29 | 50,469,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-29 to 2023-04-29 | $304.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-29 to 2023-04-29 | $109.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2023-01-29 to 2023-04-29 | $283.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-04-29 | $636.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-04-29 | $2.69bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-04-29 | $5.38bn | us-gaap:Assets |
| Current liabilities | At period end2023-04-29 | $1.63bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-04-29 | $3.36bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-04-29 | $2.02bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-23-010464. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.